In line with this, for HeLa cells, KD of RAD51 was found to result in an increased degree of cisplatin sensitivity [62], and for NSCLC cells, impaired RAD51 foci formation was associated with enhanced cisplatin sensitivity [59]. Here, RAD51 is linked to non-small cell lung carcinoma.